-
Mashup Score: 21
In this Masterclass on achievement in face of adversity, host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) sits down with Dr Eugene Braunwald, Distinguished Hersey Professor
Source: www.radcliffecardiology.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3AHA 24: LIBerate-OLE: Long-Term Efficacy of Lerodalcibep in Patients at High Risk for CVD - 4 day(s) ago
AHA Conference 2024 – Long-term safety and efficacy outcomes from 48 and 72 weeks of LIB003 (LIB Therapeutics LLC) administered to patients with CVD or at high risk for CVD on oral
Source: www.radcliffecardiology.comCategories: General Medicine News, CardiologistsTweet-
RT @TCHheart: https://t.co/N2yYfVjtuh .@djkereiakes shared LIBerate-OLE trial results at #AHA24, showing lerodalcibep's long-term efficacy…
-
-
Mashup Score: 3AHA 24 Late-Breaking Discussion: REALIZE-K: Efficacy and Safety of SZC in Patients with HFrEF Receiving Spironolactone - 4 day(s) ago
AHA Conference 2024 — REALIZE-K: Impact of sodium zirconium cyclosilicate (SZC) on HFrEF patient’s potassium levels whilst on spironolactone.Late-Breaker Host, Dr Harriette Van Spall
Source: www.radcliffecardiology.comCategories: General Medicine News, CardiologistsTweet-
RT @radcliffeCARDIO: 🎙️NEW #AHA24 Late Breaker Discussion 📽️👉 https://t.co/ypbltFJAp4 Dr @MkosiborodMD joins host 🌟Dr @hvanspall to discu…
-
-
Mashup Score: 5
Learn from your interventional, imaging and heart failure colleagues about the latest in recognizing and treating patients with mitral and tricuspid valve disease. Participate in case-based discussions, brush up on the latest clinical data and guidelines and learn more about new approved technologies for your valvular disease patients. We hope you can join us for this engaging and interactive session!
Source: www.radcliffecardiology.comCategories: General Medicine News, CardiologistsTweet-
RT @md_viviana: Looking forward to a great discussion! @RCubedduMD @DeeDeeWang. Register today https://t.co/wEhLR0z9qP
-
-
Mashup Score: 3ESC 24 Hot Line Discussion: FINEARTS-HF: Finerenone HFmEF & HFpEF - 3 month(s) ago
ESC Congress 2024 — FINEARTS-HF shows finerenone reduces cardiovascular death and total of worsening heart failure (HF) events over median follow-up of 32 months.Host, Dr Harriette Van
Source: www.radcliffecardiology.comCategories: General Medicine News, CardiologistsTweet-
RT @radcliffeCARDIO: #ESCCongress24 🔥Hot Line Discussion 📺Watch Now👉 https://t.co/heLU81SZRf Dr @hvanspall & Dr Scott Solomon discuss fin…
-
-
Mashup Score: 7ESC 24: FINE-HEART: Finerenone in HF & CKD - 3 month(s) ago
ESC Congress 2024 — Finerenone improved outcomes in two trials in patients with CKD with T2D, and in patients with HFmrEF and HFpEF.Investigator, Dr Muthiah Vaduganathan (Brigham and
Source: www.radcliffecardiology.comCategories: General Medicine News, CardiologistsTweet-
RT @radcliffeCARDIO: #ESCCongress 24 | New #Hotline data 📊with Dr @mvaduganathan Watch here📺 https://t.co/fEI8z3l6VN ➡️#FINEHEART #MRA, f…
-
-
Mashup Score: 7ESC 24: FINE-HEART: Finerenone in HF & CKD - 3 month(s) ago
ESC Congress 2024 — Finerenone improved outcomes in two trials in patients with CKD with T2D, and in patients with HFmrEF and HFpEF.Investigator, Dr Muthiah Vaduganathan (Brigham and
Source: www.radcliffecardiology.comCategories: General Medicine News, CardiologistsTweet-
RT @radcliffeCARDIO: #ESCCongress 24 | New #Hotline data 📊with Dr @mvaduganathan Watch here📺 https://t.co/fEI8z3l6VN ➡️#FINEHEART #MRA, f…
-
-
Mashup Score: 2ESC 2024 Symposium – AF Stroke Prevention: Applying New Guidance in the Real World | Radcliffe Cardiology - 4 month(s) ago
Radcliffe Medical Education is hosting a symposium entitled ‘AF Stroke Prevention: Applying New Guidance in the Real World’ at 15:15 UCT+1 on Sunday 1 September 2024 in Dublin Room at ESC 2024, ExCel Centre, London, UK.
Source: www.radcliffecardiology.comCategories: General Medicine News, Partners & KOLsTweet-
💡 Don’t miss out on our upcoming #ESC symposium on AF Stroke Prevention, chaired by the esteemed Prof Gregory Lip. 👉 https://t.co/PFYuyz4s9g Join us on Sunday 1 September 2024, 15.15-16.00 Discover: 🫀Aortic stenosis impact on stroke risk in AF 🩺 Non-pharmacological… https://t.co/l4G6WNWh4L https://t.co/0PLvWP8Wr2
-
-
Mashup Score: 2ESC 2024 Symposium – AF Stroke Prevention: Applying New Guidance in the Real World | Radcliffe Cardiology - 4 month(s) ago
Radcliffe Medical Education is hosting a symposium entitled ‘AF Stroke Prevention: Applying New Guidance in the Real World’ at 15:15 UCT+1 on Sunday 1 September 2024 in Dublin Room at ESC 2024, ExCel Centre, London, UK.
Source: www.radcliffecardiology.comCategories: General Medicine News, Partners & KOLsTweet-
💡 Don’t miss out on our upcoming #ESC symposium on AF Stroke Prevention, chaired by the esteemed Prof Gregory Lip. 👉 https://t.co/PFYuyz4s9g Join us on Sunday 1 September 2024, 15.15-16.00 Discover: 🫀Aortic stenosis impact on stroke risk in AF 🩺 Non-pharmacological… https://t.co/l4G6WNWh4L https://t.co/0PLvWP8Wr2
-
-
Mashup Score: 3Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins - 4 month(s) ago
Join Dr Jose Alvarez-Cardona (New York University School of Medicine, US), Dr Kamari Ositelu (Northwestern University, US), Dr Anjali Rao (Northwestern University, US),
Source: www.radcliffecardiology.comCategories: General Medicine News, Partners & KOLsTweet-
🩺 Don't miss this opportunity to elevate your clinical knowledge on cardiac health in cancer patients! Join us on 1 August 2024 at 14:00 BST | 09:00 EDT🔗 https://t.co/vTHpGtM07a Dive into groundbreaking insights with leading #CardioOncology experts Dr Jose Alvarez-Cardona, Dr… https://t.co/RaPuiC8JO6 https://t.co/vqcWGraZdi
-
A masterclass on #achievement in the face of adversity with Dr #EugeneBraunwald @radcliffeCARDIO Happy birthday to Dr #EB, whose contributions to our field place him in a league of his own! https://t.co/Ae6jgPNViE